Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
Published: 01 September 2020
-
Views:
1689
-
Likes:
7
-
Views:
1689
-
Likes:
7
Overview
In this series of videos Kurt Huber, Davide Capodanno, Stefan James and Roxana Mehran discuss Navigating the Antithrombotic Maze: What to do for Your ACS Patients in the Era of Contemporary PCI
Learning Objectives
- Review the clinical landscape for antiplatelet therapy in patients with ACS.
- Discuss recent data on DAPT for patients with ACS
- Provide expert insight on application in routine clinical practice
More from this programme
Part 2
Pre-treatment in NSTE-ACS – Dead or Alive?
Part 3
Choice of Antithrombotic Agent in ACS: REACT-ing to Recent Trials
Part 4
When to leave Aspirin behind?
| 1 session | |
| When to leave Aspirin behind? | Watch now |
Faculty Biographies
Davide Capodanno
Professor of Cardiology and Interventional Cardiologist
Prof Capodanno is Professor of Cardiology at the University of Catania and Interventional Cardiologist at the Azienda Ospedaliero Universitaria “Policlinico G. Rodolico-S. Marco”, Catania. He has authored more than 500 manuscripts, 5 textbooks of interventional cardiology and 17 textbook chapters, and he has delivered more than 200 invited lectures in international meetings.
Prof. Capodanno is Co-Director of the PCR Clinical Research Course and Associate Director of TCT. He is a member of the Working Group on Thrombosis of the ESC and a member of the Educative Solutions Research Group Programme of PCR. He serves as Editor-in-Chief of Eurointervention, Associate Editor of the European Heart Journal, Section Editor of Thrombosis and Haemostasis and Editorial Consultant of JACC Cardiovascular Interventions.